BMY241220C70000
- 0.01
- 0.000.00%
Bristol-Myers Squibb Newsroom
Bristol-Myers Squibb Shares Rise After Analyst Upgrade SAnd Positive Pipeline Outlook
Institutional Investors May Overlook Bristol-Myers Squibb Company's (NYSE:BMY) Recent US$5.9b Market Cap Drop as Long-term Gains Remain Positive
9 Health Care Stocks With Whale Alerts In Today's Session
Another Week, Another Index Record | Lkive Stock
Bristol Myers Squibb Terminates Agreements With Immatics Due To Ongoing Portfolio Prioritization Efforts Within BMS For Allogeneic Programs; Collaboration With BMS Under The 2019 Multi-Target TCR-T Strategic Collaboration Agreement Remains Ongoing
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Bristol-Myers Squibb Analyst Ratings
Jefferies Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Raises Target Price to $70
Jefferies Upgrades Bristol-Myers Squibb to Buy From Hold, Adjusts Price Target to $70 From $63
Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma
Express News | Century Therapeutics - Termination Effective March 12, 2025
Express News | Century Therapeutics- Bms Notified Co on Dec 12 to Terminate Collaboration Agreement With Century Therapeutics
Weekly Buzz: Tech stocks hit high scores on ominous day
Express News | Bristol-Myers Squibb Co Files for Mixed Shelf; Size Not Disclosed - SEC Filing
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Market Mixed on Friday the 13th | Livestock
Bristol-Myers Squibb Hits 4-week Low
Thursday Ends in Index Declines | Wall Street Today